Gene · 10347
Papers1,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Interplay between Cannabinoid Receptors and Microglia in the Pathophysiology of Alzheimer's Disease. | J Clin Med | 2023 | 38068253 | PubTator, text mining | PubMed |
| Liquid Biopsy in Alzheimer's Disease Patients Reveals Epigenetic Changes in the PRLHR Gene. | Cells | 2023 | 38067107 | PubTator, text mining | PubMed |
| Patterns of Gene Expression, Splicing, and Allele-Specific Expression Vary among Macular Tissues and Clinical Stages of Age-Related Macular Degeneration. | Cells | 2023 | 38067097 | PubTator, text mining | PubMed |
| Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease. | Cell Mol Biol Lett | 2023 | 38031028 | PubTator, text mining | PubMed |
| Relationship Between FERMT2, CELF1, COPI, CHRNA2, and ABCA7 Genetic Polymorphisms and Alzheimer's Disease Risk in the Southern Chinese Population. | J Alzheimers Dis Rep | 2023 | 38025799 | PubTator, text mining | PubMed |
| Relationship Between Retinal Layer Thickness and Genetic Susceptibility to Age-Related Macular Degeneration in Asian Populations. | Ophthalmol Sci | 2023 | 38025159 | PubTator, text mining | PubMed |
| ATP-dependent transporters: emerging players at the crossroads of immunity and metabolism. | Front Immunol | 2023 | 38022644 | PubTator, text mining | PubMed |
| Emerging Alzheimer's disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions. | Front Aging Neurosci | 2023 | 38020773 | PubTator, text mining | PubMed |
| ABCB1 Regulates Immune Genes in Breast Cancer. | Breast Cancer (Dove Med Press) | 2023 | 38020048 | PubTator, text mining | PubMed |
| Liver X receptor alpha ensures blood-brain barrier function by suppressing SNAI2. | Cell Death Dis | 2023 | 38016947 | PubTator, text mining | PubMed |
| Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms. | Genes (Basel) | 2023 | 38002991 | PubTator, text mining | PubMed |
| Protein Biomarkers Shared by Multiple Neurodegenerative Diseases Are Calmodulin-Binding Proteins Offering Novel and Potentially Universal Therapeutic Targets. | J Clin Med | 2023 | 38002659 | PubTator, text mining | PubMed |
| Alzheimer's genes in microglia: a risk worth investigating. | Mol Neurodegener | 2023 | 37986179 | PubTator, text mining | PubMed |
| Simple model systems reveal conserved mechanisms of Alzheimer's disease and related tauopathies. | Mol Neurodegener | 2023 | 37950311 | PubTator, text mining | PubMed |
| CSF biomarker analysis of ABCA7 mutation carriers suggests altered APP processing and reduced inflammatory response. | Alzheimers Res Ther | 2023 | 37946268 | PubTator, text mining | PubMed |
| The relationship between Alzheimer disease and thyroiditis: A two-sample Mendelian randomization study. | Medicine (Baltimore) | 2023 | 37933065 | PubTator, text mining | PubMed |
| Human isogenic cells of the neurovascular unit exert transcriptomic cell type-specific effects on a blood-brain barrier in vitro model of late-onset Alzheimer disease. | Fluids Barriers CNS | 2023 | 37907966 | PubTator, text mining | PubMed |
| Patient with PSEN1 Glu318Gly and Other Possible Disease Risk Mutations, Diagnosed with Early Onset Alzheimer's Disease. | Int J Mol Sci | 2023 | 37895139 | PubTator, text mining | PubMed |
| Overlapping Neuroimmune Mechanisms and Therapeutic Targets in Neurodegenerative Disorders. | Biomedicines | 2023 | 37893165 | PubTator, text mining | PubMed |
| Are Ischemic Stroke and Alzheimer's Disease Genetically Consecutive Pathologies? | Biomedicines | 2023 | 37893101 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10347/papers?page=8